SecBot SecBot
8-K ·Filed Aug 25, 2026

CABR

Caring Brands, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed2mo ago SEC0001493152-26-040102
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The massive potential dilution (up to 22M warrant shares plus Series B conversion shares vs. a $14M market cap) and deeply discounted conversion/exercise prices signal severe financial distress. Traders should expect significant downward pressure on CABR common stock as the market prices in the overhang. Monitor for stockholder approval filings and any registration statement for resale, which would accelerate the dilutive overhang.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
CABR ▼ -8.65% at T+20d
SHORT call ✓ call won +8.65% · α vs SPY +8.87% · entry $1.33 → $1.22
Next anchor: T+60d in 22d
Latest observation: T+41 +41.40% FF3 residual α
Entry = T+0 close
Aug 25, 2026
via day close
T+1d
+3.76%
call -3.76% · α -3.10%
$1.38
settled 2mo ago
T+5d
+9.77%
call -9.77% · α -9.89%
$1.46
settled 8w ago
T+20d
-8.65%
call +8.65% · α +8.87%
$1.22
settled 5w ago
T+60d
Pending
in 22d

Price Chart

Loading chart...

Executive Summary

Caring Brands entered into a securities purchase agreement to raise up to $11M through a private placement of Series B convertible preferred stock and warrants, with significant potential dilution. The company also amended its Series A preferred certificate of designation to remove a redemption right and adjust anti-dilution provisions. The $11M capital raise is a material event for a $14M market cap company, but the deeply dilutive terms (conversion at $0.70 vs. likely market price, full-ratchet anti-dilution, and warrants for up to 22M shares) signal distressed financing conditions and create massive overhang, making this bearish for common stockholders.

Key Financial Metrics

Deal Value
$11.0M
Offering Size
$11.0M

Key Facts

  • Company entered into a Securities Purchase Agreement to sell up to 11,000 shares of Series B Convertible Preferred Stock at $1,000/share for aggregate gross proceeds of up to $11,000,000.
  • Series B Preferred Stock is convertible into common stock at $0.70 per share, subject to full-ratchet anti-dilution adjustment.
  • Investors also received Series A Warrants to purchase up to 11,000,000 shares at $0.825/share and Series B Warrants to purchase up to 11,000,000 shares at $0.95/share, each with a 5-year term and full-ratchet anti-dilution.
  • The Series B Preferred Stock accrues an 8% annual dividend payable in cash or common stock at the holder's election.
  • The Amended Series A Certificate of Designation eliminated the holders' right to require redemption upon a triggering event and increased designated shares from 4,000 to 4,500.
  • The total number of shares issuable upon conversion/exercise is limited to 19.99% of outstanding common stock unless stockholder approval is obtained.
  • Company agreed to file a resale registration statement within 30 trading days and use best efforts to have it effective within 60 calendar days, with liquidated damages of 1% per month for failure.

Financial Impact

Up to $11,000,000 gross proceeds from sale of Series B Preferred Stock, with potential issuance of up to 22,000,000 common shares upon full warrant exercise and additional shares upon Series B conversion at $0.70/share.

dilutiondebtshare count

Risk Factors

  • Massive dilution from conversion of Series B Preferred Stock and exercise of warrants, potentially overwhelming the current share count.
  • Full-ratchet anti-dilution protection on both preferred and warrants means any future lower-priced issuance will further reduce conversion/exercise prices, compounding dilution.
  • 8% dividend on Series B Preferred Stock creates a cash or share obligation that strains the company's already limited resources.
  • Registration rights agreement with liquidated damages creates a financial penalty risk if the company fails to register shares for resale on time.
  • The company's $14M market cap is small relative to the $11M offering, making the capital structure highly unstable.

Market Snapshot

Exchange
Nasdaq
Sector
Perfumes, Cosmetics & Other Toilet Preparations

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-040102
Document: 0001493152-26-040102-index.html0001493152-26-040102
Document: 0001493152-26-040102.txt0001493152-26-040102
13 reports for CABR
Performance horizon
100% Hit rate @ T+20 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+5▲ +21.92%Sep 2, 2026
Filters
Rows
Reports for CABR — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
NEUTRAL ★ 4/10
$1.05awaiting T+20—$1.12 (+6.19%)
Sep 11, 2026
6w ago
8-K
MIXED ★ 6/10
$1.19 $1.16▼ −2.52%▼ −4.39%$1.12 (−6.30%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$1.19 $1.16▼ −2.52%▼ −4.39%$1.12 (−6.30%)
Sep 2, 2026
7w ago
8-K
BEARISH ★ 6/10
$1.46 $1.19▲ +18.49%▲ +18.34%$1.12 (+23.63%)
Sep 1, 2026
8w ago
8-K
MIXED ★ 7/10
$1.35 $1.19▼ −11.85%▼ −12.17%$1.12 (−17.41%)
Aug 25, 2026
8w ago
8-K
BEARISH ★ 7/10
$1.33 $1.22▲ +8.65%▲ +8.87%$1.12 (+16.17%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$1.34 $1.26▼ −5.62%▼ −5.22%$1.12 (−16.48%)
Jul 17, 2026
14w ago
8-K
BEARISH ★ 7/10
$1.37 $1.33▲ +2.56%▲ +6.68%$1.12 (+18.32%)
Jun 1, 2026
21w ago
DEFA14A
NEUTRAL ★ 2/10
$1.25 $1.42▲ +14.06%▲ +15.62%$1.12 (−10.44%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$1.30 $1.24▼ −4.62%▼ −3.32%$1.12 (−14.23%)
Showing 10 of 13

US Market Status

Market Open — Closes in 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 25, 2026